DBRG vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 26, 2026

DBRG

59.0
AI Score
VS
CNS Wins

CNS

67.8
AI Score

Investment Advisor Scores

DBRG

59score
Recommendation
BUY

CNS

68score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DBRG CNS Winner
Forward P/E 10.9529 18.4502 DBRG
PEG Ratio 3.0554 1.6881 CNS
Revenue Growth 58.9% 12.2% DBRG
Earnings Growth 1099.3% 31.9% DBRG
Tradestie Score 59.0/100 67.8/100 CNS
Profit Margin 54.3% 28.8% DBRG
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD DBRG

Relative Price Performance (Last 90 Days)

DBRG 1M: +0.4% · 3M: +1.4% CNS 1M: -5.6% · 3M: -6.9%

Current Technical Phase

DBRG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 62.8 · Price: $16.00

CNS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 36

RSI (14): 36.2 · Price: $73.12

Fundamentals Snapshot

Metric DBRG CNS
Market Cap — —
Forward P/E 19.5 18.4
Trailing P/E 10.1 22.4
Revenue (TTM) — —
Revenue Growth 0.6% 0.1%
Gross Margin 1.0% 0.5%
Operating Margin 0.5% 0.3%
EPS 1.59 3.26
Dividend Yield 0.00% 0.04%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.